ada guidelines glp-1 Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists ADA guidelines for Diabetes 2026

Medicare Coverage for Wegovy (November 2025) Novo Nordisk announced a program offering Wegovy at $50/month for eligible Medicare beneficiaries

While auto-injector pens manufactured by pharmaceutical companies are safe, Dr

Change in HbA1c, eGFR, and cholesterol levels Biomarker values were assessed in posttreatment selected patients who were alive and had a measurement of the respective biomarker before and 312 months after treatment initiation, as the first available measurement within 12 months after treatment initiation

these medications are a combination of GLP-1 plus gastric inhibitory polypeptide agonist (GIP) Semaglutide and tirzepatide are marketed for Type 2 diabetes and weight management under different brand names

Safety Considerations and Clinical Eligibility GLP-1 medications, as described in SkinnyRx's published patient protocols, are intended for adults aged 18 and older

And I'm a big fan of that because as a clinician you need some guide, some efficient and effective way to treat the patient in front of you